Bruce Booth, an insider at Kymera Therapeutics, Inc. (KYMR), recently divested a significant portion of their holdings. On March 4, 2026, Booth sold 71,814 shares of the company's stock at an average price of $90.13 per share. This transaction amounts to a total value of approximately $6.47 million.
This sale comes amidst other recent insider selling activity at Kymera Therapeutics, with multiple executives, including Jacobs Bruce N., Gollob Jared, and Chadwick Jeremy G, also reporting stock sales on the same date. Insider sales can be driven by various factors, including portfolio diversification or tax planning, and do not necessarily indicate a negative outlook on the company's future performance.